ArticleJCO precision oncology2025

Sustained Response to Pan-BRAF Inhibitor Plixorafenib (FORE8394, PLX8394) in a Young Adult With Neurodegenerative Langerhans Cell Histiocytosis.

Joanna S Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.